Fosaprepitant

Fosaprepitant
Pharmacopoeia IH
ChemSpider ID 189912
Formula C23H22F7N4O6P
Elimination Half-life 9 to 13 Hours (aprepitant)
Click to view more

Preferred Buyer From

Location All Countries Except India

Product Details

Form
Powder
Color
White

Fosaprepitant is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved by the United States Food and Drug Administration on January 25, 2008 and by the European Medicines Agency on January 11 of the same year.

Yes! I am interested

Looking for "Fosaprepitant" ?

Explore More Products


Raise your Query

Hi! Simply click below and type your query.

Our experts will reply you very soon.

WhatsApp Us